Atrion Corporation (ATRI) Business Metric Overview - Stocknear

Atrion Corporation

NASDAQ: ATRI · Real-Time Price · USD
459.92
0.26 (0.06%)
At close: Aug 20, 2024, 10:00 PM

Atrion Revenue Breakdown

Period Ending Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018
Cardiovascular Revenue 11.3M 10.84M 14.82M 10.23M 14.56M 14.58M 15.42M 11.4M 13.29M 13M 13.21M
Cardiovascular Revenue Growth +4.21% -26.87% +44.84% -29.73% -0.10% -5.45% +35.28% -14.24% +2.22% -1.57% n/a
Fluid Delivery Revenue 16.51M 21.76M 22.35M 17.78M 17.89M 18.29M 18.16M 16.57M 17.11M 18.13M 18.8M
Fluid Delivery Revenue Growth -24.12% -2.63% +25.67% -0.59% -2.17% +0.68% +9.58% -3.12% -5.64% -3.57% n/a
Ophthalmology Revenue 1.17M 936K 863K 1.47M 1.56M 1.82M 2.28M n/a 2.77M 2.85M 2.79M
Ophthalmology Revenue Growth +25.11% +8.46% -41.21% -5.66% -14.36% -20.41% n/a n/a -2.95% +2.41% n/a
Other Revenue 4.8M 4.43M 5.56M 4.98M n/a n/a n/a n/a n/a n/a n/a
Other Revenue Growth +8.47% -20.31% +11.63% n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2022 Sep 30, 2022
European Union Revenue 23.94M 6.37M
European Union Revenue Growth +275.77% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 13.99M 7.56M 8.07M 7.8M 8.27M 8.98M 8.05M 6.8M 8.25M 7.62M 8.01M 6.92M 6.63M 6.1M 6.12M 5.93M 6.33M 6.47M 6.07M 6.08M 6.4M 6.57M 5.92M 6.04M 6.35M 6.25M 5.99M 5.78M 6.15M 5.76M 5.62M 5.08M 5.54M 5.68M 5.4M 5.25M 6M 5.48M
Selling, General, and Administrative Revenue Growth +85.12% -6.31% +3.42% -5.65% -7.94% +11.58% +18.39% -17.60% +8.32% -4.94% +15.81% +4.41% +8.67% -0.42% +3.32% -6.38% -2.15% +6.64% -0.25% -5.00% -2.57% +11.02% -1.97% -4.97% +1.71% +4.33% +3.65% -6.08% +6.70% +2.63% +10.48% -8.30% -2.46% +5.18% +2.97% -12.46% +9.44% n/a
Research and Development Revenue 1.32M 1.65M 1.58M 1.87M 1.61M 1.63M 1.32M 1.25M 1.55M 1.38M 1.52M 1.39M 1.45M 1.31M 1.48M 1.39M 1.09M 1.68M 1.36M 1.36M 1.22M 1.09M 1.37M 1.2M 1.6M 1.34M 1.74M 1.15M 1.37M 1.54M 2M 1.56M 1.6M 1.42M 1.55M 1.56M 1.67M 1.56M
Research and Development Revenue Growth -20.00% +4.10% -15.20% +16.30% -1.41% +23.48% +5.52% -19.45% +12.78% -9.70% +9.48% -3.60% +10.31% -11.49% +6.63% +27.11% -35.15% +23.82% +0.07% +11.03% +11.78% -19.96% +13.62% -24.89% +19.81% -23.24% +51.70% -16.01% -11.11% -22.97% +27.75% -2.07% +12.78% -8.88% -0.58% -6.35% +6.99% n/a
Sales and Marketing Revenue 2.71M 2.77M 2.53M 2.35M 2.32M 2.73M 2.33M 2.31M 2.63M 2.52M 2.18M 2.08M 1.87M 1.93M 1.86M 1.89M 1.7M 2.07M 2.24M 2.09M 2.1M 2.38M 2.17M 2.1M 2.04M 2.02M 1.95M 1.69M 1.86M 1.75M 1.74M 1.47M 1.66M 1.74M 1.52M 1.32M 1.68M 1.52M
Sales and Marketing Revenue Growth -2.09% +9.39% +7.92% +1.34% -15.03% +16.99% +1.08% -12.29% +4.45% +15.51% +4.71% +11.05% -2.70% +3.55% -1.48% +10.86% -17.73% -7.55% +7.03% -0.29% -12.00% +9.76% +3.18% +2.93% +1.34% +3.59% +15.20% -9.28% +6.64% +0.46% +18.29% -11.60% -4.09% +14.30% +14.83% -21.40% +10.66% n/a